Progesterone Market Report 2026

Progesterone Market Overview

• Progesterone market size has reached to $1.79 billion in 2025 • Expected to grow to $3.54 billion in 2030 at a compound annual growth rate (CAGR) of 14.5% • Growth Driver: Rising Incidence Of Hormonal Disorders Fueling The Growth Of The Market Due To Increasing Demand For Hormonal Balance Therapies • Market Trend: Advancements In Progesterone Delivery With Soft Vaginal Capsules • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Progesterone Market?

Progesterone is a steroid hormone primarily involved in the menstrual cycle, pregnancy, and embryogenesis in humans and other species. It prepares the endometrium (lining of the uterus) for the potential implantation of a fertilized egg, maintains early pregnancy, and inhibits further ovulation during pregnancy. Progesterone is also used in hormone replacement therapy and birth control pills (in synthetic forms called progestins).  The main product types of progesterone are natural progesterone and synthetic progesterone. Natural progesterone, often referred to as bioidentical progesterone, is a hormone derived from plants such as soybeans or wild yams. These are available in both branded and generic forms and can be administered via various routes, including injectable, oral, transdermal, and others. It is used for multiple applications such as menopause management, contraception, dysfunctional uterine bleeding, hyperplastic precursor lesions, endometrial cancer, and more. The primary end-users include hospitals, clinics, research institutes, and other healthcare facilities.

What Is The Progesterone Market Growth Forecast?

The progesterone market size is expected to see rapid growth in the next few years. It will grow to $3.54 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to development of synthetic progestins and advanced delivery systems, rising demand for personalized hormone therapy, growth in fertility and contraceptive clinics, increasing research in endometrial cancer treatment, adoption of minimally invasive administration routes. Major trends in the forecast period include rising demand for natural progesterone formulations, growth in hormone replacement therapy (hrt) usage, increasing adoption of injectable and transdermal routes, expansion of contraceptive and fertility treatments, focus on personalized medicine and endometrial health.

Global Progesterone Market Segmentation

1) By Product Type: Natural Progesterone, Synthetic Progesterone 2) By Drug Type: Branded, Generic 3) By Route Of Administration: Injectable, Oral, Transdermal, Other Routes Of Administration 4) By Application: Menopause, Contraception, Dysfunctional Uterine Bleeding, Hyperplastic Precursor Lesions, Endometrial Cancer, Other Applications 5) By End-User: Hospitals, Clinics, Research Institutes, Other End-Users Subsegments: 1) By Natural Progesterone: Oral Capsules, Vaginal Gels, Creams, Injections, Suppositories 2) By Synthetic Progesterone: Progestins, Oral Contraceptives, Hormone Replacement Therapy (HRT) Formulations, Injectable Contraceptives, Intrauterine Devices

What Is The Driver Of The Progesterone Market?

The increasing prevalence of hormonal disorders is expected to propel the growth of the progesterone market going forward. Hormonal disorders refer to medical conditions caused by imbalances or dysfunctions in the body’s endocrine system, which produces and regulates hormones that control vital functions such as metabolism, growth, reproduction, and mood. The increasing prevalence of hormonal disorders is due to modern lifestyle factors, including poor diet, chronic stress, lack of physical activity, and exposure to environmental toxins. Progesterone helps in the management of hormonal disorders by restoring hormonal balance, regulating menstrual cycles, and reducing symptoms linked to estrogen dominance. It also supports the function of other hormones, such as estrogen and cortisol, helping to stabilize overall endocrine system activity and alleviate conditions such as polycystic ovary syndrome (PCOS) and premenstrual syndrome (PMS). For instance, in January 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, polycystic ovary syndrome is a significant public health issue and one of the most common hormonal disorders in women of reproductive age, affecting an estimated 6–13% yearly. Therefore, the increasing prevalence of hormonal disorders drives the growth of the progesterone industry.

Key Players In The Global Progesterone Market

Major companies operating in the progesterone market are Pfizer Inc., Johnson & Johnson, Merck & Co Inc., Allergan plc, AbbVie Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd, Gedeon Richter Plc., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Cadila Pharmaceuticals Ltd., Aspen Pharmacare, BIOCON Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Beximco Pharmaceuticals Ltd., Besins healthcare (UK) limited., Sichuan Deebio Pharmaceutical Co. Ltd., Changzhou Siyao Pharmaceuticals Co. Ltd., Shanghai Shyndec Pharmaceutical Co. Ltd.

Global Progesterone Market Trends and Insights

Major companies operating in the progesterone market are focusing on developing innovative formulations, such as soft vaginal capsules, to improve patient compliance and enhance drug absorption. Soft vaginal capsules are smooth, gel-like inserts designed for vaginal use that help deliver medication directly to the vaginal area for treating infections, supporting hormonal balance, or maintaining overall vaginal health. For instance, in April 2024, Besins Healthcare (UK) Limited, a UK-based pharmaceutical manufacturing company, launched Prometrium 400mg soft vaginal capsules for preventing miscarriage in women with early pregnancy bleeding and a history of recurrent miscarriage. This innovative formulation is the first licensed product in the UK and is designed to improve patient compliance and therapeutic outcomes by offering a targeted, non-invasive delivery method that enhances progesterone absorption at the site of action.

What Are Latest Mergers And Acquisitions In The Progesterone Market?

In October 2024, Audax Private Equity, a US-based private equity firm, acquired the clinical services business of Avantor, Inc. for an undisclosed amount. With this acquisition, Audax aims to establish the business, now rebranded as Resonant Clinical Solutions, as an independent platform in the outsourced clinical trial services sector, enhancing its service offerings and leveraging its long-standing customer relationships. Avantor, Inc. is a US-based biotechnology company that specializes in providing progesterone.

Regional Insights

North America was the largest region in the progesterone market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Progesterone Market?

The progesterone market consists of sales of oral capsules, vaginal gels, creams, injections, and intrauterine devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Progesterone Market Report 2026?

The progesterone market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the progesterone industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.